Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
| Business Activity | PASS |
| Debt Ratio (0.01%) | PASS |
| Cash Ratio (0.57%) | FAIL |
| Receivables Ratio (0.30%) | PASS |
| Revenue Ratio (0.08%) | FAIL |
| Overall | FAIL |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-06-03 | 2.14 | Pending | — |
| 2026-03-04 | 1.94 | 2.06 | +6.5% |
| 2025-11-20 | 1.95 | 2.04 | +4.5% |
| 2025-08-27 | 1.90 | 1.99 | +4.8% |
| 2025-05-28 | 1.74 | 1.97 | +13.0% |
| 2025-03-05 | 1.58 | 1.74 | +10.1% |
| 2024-12-05 | 1.58 | 1.75 | +10.7% |
| 2024-08-28 | 1.53 | 1.62 | +5.6% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-01-31 | $836.0M | $244.2M | $254.2M | $622.5M | $245.9M | 1.49 |
| 2025-10-31 | $811.2M | $236.2M | $250.6M | $611.8M | $240.9M | 1.44 |
| 2025-07-31 | $789.1M | $200.3M | $206.0M | $593.8M | $195.9M | 1.23 |
| 2025-04-30 | $759.0M | $228.2M | $243.6M | $585.2M | $233.7M | 1.40 |
| 2025-01-31 | $720.9M | $195.6M | $198.4M | $539.9M | $188.4M | 1.20 |
| 2024-10-31 | — | — | — | — | — | — |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-04-30 | HUNG PRISCILLA C | Director | 750 | $116.7K |
| 2026-04-10 | HUNG PRISCILLA C | Director | 750 | $115.1K |
| 2026-04-01 | VAN WAGENER BRIAN | Chief Financial Officer | 872 | — |
| 2026-04-01 | KONDATH VIPIN | Officer | 2,603 | — |
| 2026-04-01 | SCHWENGER THOMAS D | President | 2,043 | — |
| 2026-04-01 | ZUPPAS ELENI NITSA A | President | 8,998 | — |
| 2026-04-01 | FADDIS JONATHAN W | General Counsel | 8,726 | — |
| 2026-03-05 | SCHWENGER THOMAS D | President | 1,000 | $200.0K |
| 2026-02-27 | RITTER GORDON | Director | 297 | — |
| 2026-02-27 | HUNG PRISCILLA C | Director | 262 | — |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 11.6M | $1.9B | 0.1% |
| Vanguard Portfolio Management LLC | 7.4M | $1.2B | 0.0% |
| Vanguard Capital Management LLC | 6.7M | $1.1B | 0.0% |
| Alliancebernstein L.P. | 6.3M | $1.0B | 0.0% |
| Linonia Partnership LP | 4.9M | $788.8M | 0.0% |
| Principal Financial Group, Inc. | 4.1M | $663.4M | 0.0% |
| State Street Corporation | 3.6M | $578.0M | 0.0% |
| T. Rowe Price Investment Management, Inc. | 3.4M | $545.5M | 0.0% |
| Geode Capital Management, LLC | 3.3M | $530.6M | 0.0% |
| FMR, LLC | 2.6M | $418.6M | 0.0% |
Buy
Hold
Sell
Strong Sell
$19.7B
3.64
0.924
28
$3.2B
$95.9M
+23.2%
1.87
3.25
0.0%
7,928
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-06-03 | $2.14 | Pending | — |
| 2026-03-04 | $1.94 | $2.06 | +6.5% |
| 2025-11-20 | $1.95 | $2.04 | +4.5% |
| 2025-08-27 | $1.90 | $1.99 | +4.8% |
| 2025-05-28 | $1.74 | $1.97 | +13.0% |
| 2025-03-05 | $1.58 | $1.74 | +10.1% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($262.68, 28 analysts) | |||
| 10 | $1,663.40 | +$963.40 (58%) | 3.9R |
| 50 | $8,317.00 | +$4,817.00 (58%) | 3.9R |
| 100 | $16,634.00 | +$9,634.00 (58%) | 3.9R |
| To Fair Value ($247.00) | |||
| 10 | $1,663.40 | +$806.60 (48%) | 3.2R |
| 50 | $8,317.00 | +$4,033.00 (48%) | 3.2R |
| 100 | $16,634.00 | +$8,066.00 (48%) | 3.2R |
- Elevated short interest (3.25 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| DOCU | 0.428 |
| WDAY | 0.420 |
| FRSH | 0.410 |
| BL | 0.409 |
| NTSK | 0.407 |
| Ticker | Correlation |
|---|---|
| PAVREIT.KL | -0.220 |
| NG.L | -0.172 |
| MGRT | -0.140 |
| SVT.L | -0.136 |
| CKISY | -0.128 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker’s recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.
Related Tickers
Similar in Healthcare
Also in TE500